Back to search

Article

CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting

2020-12-19

Abstract excerpt

<h4>ABSTRACT</h4> The well-recognized genome editing ability of the CRISPR-Cas system has triggered significant advances in CRISPR diagnostics. This has prompted an interest in developing new biosensing applications for nucleic acid detection. Recently, such applications have been engineered for detection of SARS-CoV-2. Increased demand for testing and consumables of RT-qPCR assays has led to the use of alternate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1dc61be5-82d3-57d9-82ca-fc25a4b22c10
DOI
10.1101/2020.12.17.20228593
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical settingDOI 10.1101/2020.12.17.20228593
Select a neighboring publication to make it the new centre.